BRIEF published on 09/19/2024 at 18:08, 2 months 3 days ago Funding Circle Plc Executes Share Buyback London Stock Exchange Share Buyback Equity Purchase Numis Securities Funding Circle
PRESS RELEASE published on 09/19/2024 at 18:03, 2 months 3 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of 150,000 ordinary shares. London Stock Exchange transactions details provided London Stock Exchange Share Buyback Cancellation Funding Circle Plc Transaction Details
BRIEF published on 09/18/2024 at 18:13, 2 months 4 days ago Funding Circle Plc Announces Share Buyback Transaction Share Buyback Market Abuse Regulation Stock Exchange Numis Securities Funding Circle
PRESS RELEASE published on 09/18/2024 at 18:08, 2 months 4 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase and cancellation of 150,762 ordinary shares. Company's issued share capital will be 336,798,152 shares post-cancellation London Stock Exchange Ordinary Shares Share Purchase Funding Circle Plc Share Cancellation
BRIEF published on 09/17/2024 at 18:05, 2 months 5 days ago Funding Circle Plc: POS-Transaction in Own Shares London Stock Exchange Share Repurchase Market Abuse Regulation Funding Circle Stock Buy-back
PRESS RELEASE published on 09/17/2024 at 18:00, 2 months 5 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchasing and cancelling 70,898 ordinary shares, impacting share capital. Detailed transaction info provided Share Capital London Stock Exchange Cancellation Funding Circle Plc Shares Purchase
BRIEF published on 09/16/2024 at 18:37, 2 months 6 days ago Funding Circle Plc: Transaction in Own Shares Share Buy-back Share Capital London Stock Exchange Market Abuse Regulation Funding Circle
PRESS RELEASE published on 09/16/2024 at 18:32, 2 months 6 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 54,642 ordinary shares on the London Stock Exchange as part of its buy-back program London Stock Exchange Share Buyback Own Shares Cancellation Funding Circle Plc
BRIEF published on 09/13/2024 at 17:52, 2 months 9 days ago Funding Circle Plc: Share Buy-Back and Cancellation Share Buy-back London Stock Exchange Market Abuse Regulation Numis Securities Funding Circle
PRESS RELEASE published on 09/13/2024 at 17:47, 2 months 9 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 105,780 ordinary shares, facilitating a buy-back program on the London Stock Exchange London Stock Exchange Shares Buy-back Program Cancellation Funding Circle Plc
Published on 11/22/2024 at 23:55, 15 hours 17 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 15 hours 42 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 16 hours 7 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 16 hours 42 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 20 hours 57 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 21 hours 18 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 22 hours 16 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 23 hours 12 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 8 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 19 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 21 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 21 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
